Expression of CXCL10 (IP-10) and CXCL11 (I-TAC) chemokines during Mycobacterium tuberculosis infection and immunoprophylaxis with Mycobacterium indicus pranii (Mw) in guinea pig

Infection, Genetics and Evolution

Volumn 13, Issue 1, 2013, Pages 11-17

  Rawat, Krishna Dutta ^a   Chahar, Mamta ^a   Reddy, P V J ^a   Gupta, Pushpa ^a   Shrivastava, Nalini ^b   Gupta, U D ^a   Natrajan, M ^a   Katoch, V M ^c   Katoch, Kiran ^a   Chauhan, D S ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^b JIWAJI UNIVERSITY   (India)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Chemokines; CXCL10; CXCL11; Immunoprophylaxis; Mycobacterium tuberculosis

Indexed keywords

CXCL11 CHEMOKINE; ETHAMBUTOL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOMODULATING AGENT; ISONIAZID; MYCOBACTERIUM VACCINE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG POTENTIATION; EXPERIMENTAL INFECTION; GUINEA PIG; IMMUNOPROPHYLAXIS; LUNG PARENCHYMA; MONOTHERAPY; MYCOBACTERIUM; MYCOBACTERIUM INDICUS PRANII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; TUBERCULOSIS; UPREGULATION;

ANIMALS; BACTERIAL LOAD; CHEMOKINE CXCL10; CHEMOKINE CXCL11; GENE EXPRESSION; GUINEA PIGS; LUNG; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; TIME FACTORS; TUBERCULOSIS;

ANIMALIA; CAVIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84870175646     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.10.002     Document Type: Article

References (38)

1. Actor J.K., Olsen M., Jagannath C., Hunter R.L. Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis. J. Interferon Cytokine Res. 1999, 19:1183-1193.
2. Allen S.S., McMurray D.N. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs. Infect. Immun. 2003, 71:4271-4277.
3. Almeida Cde S., Abramo C., Alves C.C., Mazzoccoli L., Ferreira A.P., Teixeira H.C. Anti-mycobacterial treatment reduces high plasma levels of CXC-chemokines detected in active tuberculosis by cytometric bead array. Mem. Inst. Oswaldo Cruz 2009, 104:1039-1041.
4. Cardona P.J., Llatjos R., Gordillo S., Diaz J., Ojanguren I., Ariza A., Ausina V. Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand. J. Immunol. 2000, 52:156-163.
5. Chiu B.C., Freeman C.M., Stolberg V.R., Komuniecki E., Lincoln P.M., Kunkel S.L., Chensue S.W. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am. J. Respir. Cell Mol. Biol. 2003, 29:106-116.
6. Faujdar J., Gupta P., Natrajan M., Das R., Chauhan D.S., Katoch V.M., Gupta U.D. Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis. Indian J. Med. Res. 2011, 134:696-703.
7. Grover A.A., Kim H.K., Wiegeshaus E.H., Smith D.W. Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70°C. J. Bacteriol. 1967, 94:832-835.
8. Gupta A., Geetha N., Mani J., Upadhyay P., Katoch V.M., Natrajan M., Gupta U.D., Bhaskar S. Immunogenicity and protective efficacy of " Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route. Infect. Immun. 2009, 77:223-231.
9. Jo E.K., Park J.K., Dockrell H.M. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr. Opin. Infect. Dis. 2003, 16:205-210.
10. Kar H.K., Sharma A.K., Misra R.S., Beena K.R., Zaheer S.A., Mukherjee R., Mukherjee A., Parida S.K., Walia R., Nair N.S., et al. Reversal reaction in multibacillary leprosy patients following MDT with and without immunotherapy with a candidate for an antileprosy vaccine. Mycobacterium w. Lepr. Rev. 1993, 64:219-226.
11. Katoch K., Katoch V.M., Natrajan M., Bhatia A.S., Sreevatsa, Gupta U.D., Sharma V.D., Shivannavar C.T., Patil M.A., Bharadwaj V.P. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy. Int. J. Lepr. Other Mycobact. Dis. 1995, 63:202-212.
12. Katoch K., Singh P., Adhikari T., Benara S.K., Singh H.B., Chauhan D.S., Sharma V.D., Lavania M., Sachan A.S., Katoch V.M. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis. Vaccine 2008, 26:1228-1234.
13. Kohmo S., Kijima T., Mori M., Minami T., Namba Y., Yano Y., Yoneda T., Takeda Y., Kitada S., Yamaguchi T., Tachibana I., Yokota S. CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy. Tuberculosis (Edinb) 2012, 92:248-252.
14. Lande R., Giacomini E., Grassi T., Remoli M.E., Iona E., Miettinen M., Julkunen I., Coccia E.M. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol. 2003, 170:1174-1182.
15. Lee J.S., Lee J.Y., Son J.W., Oh J.H., Shin D.M., Yuk J.M., Song C.H., Paik T.H., Jo E.K. Expression and regulation of the CC-chemokine ligand 20 during human tuberculosis. Scand. J. Immunol. 2008, 67:77-85.
16. Lim J., Derrick S.C., Kolibab K., Yang A.L., Porcelli S., Jacobs W.R., Morris S.L. Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin. Vaccine Immunol. 2009, 16:122-126.
17. Lyons M.J., Yoshimura T., McMurray D.N. Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis. Tuberculosis (Edinb) 2004, 84:283-292.
18. McMurray D.N. Recent progress in the development and testing of vaccines against human tuberculosis. Int. J. Parasitol. 2003, 33:547-554.
19. Mohammed K.A., Nasreen N., Ward M.J., Mubarak K.K., Rodriguez-Panadero F., Antony V.B. Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy. J. Infect. Dis. 1998, 178:1450-1456.
20. Narang T., Kaur I., Kumar B., Radotra B.D., Dogra S. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Int. J. Lepr. Other Mycobact. Dis. 2005, 73:105-114.
21. Orme I.M. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 1998, 6:94-97.
22. Orme I.M., Cooper A.M. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today 1999, 20:307-312.
23. Orme I.M., McMurray D.N., Belisle J.T. Tuberculosis vaccine development: recent progress. Trends Microbiol. 2001, 9:115-118.
24. Peters W., Ernst J.D. Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. Microbes Infect. 2003, 5:151-158.
25. Phalen S.W., McMurray D.N. T-lymphocyte response in a guinea pig model of tuberculous pleuritis. Infect. Immun. 1993, 61:142-145.
26. Pokkali S., Das S.D., Logamurthy R. Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine 2008, 41:307-314.
27. Sadek M.I., Sada E., Toossi Z., Schwander S.K., Rich E.A. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am. J. Respir. Cell Mol. Biol. 1998, 19:513-521.
28. Salam N., Gupta S., Sharma S., Pahujani S., Sinha A., Saxena R.K., Natarajan K. Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells. PLoS ONE 2008, 3:e2869.
29. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., Hamid Q., Luster A.D. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 1999, 162:3549-3558.
30. Singh I.G., Mukherjee R., Talwar G.P. Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w. Vaccine 1991, 9:10-14.
31. Talwar G.P. Concluding comments on development of a vaccine against leprosy. Lepr. India 1978, 50:597-598.
32. Talwar G.P., Ahmed N., Saini V. The use of the name Mycobacterium w for the leprosy immunotherapeutic bacillus creates confusion with M. tuberculosis-W (Beijing strain): a suggestion. Infect. Genet. Evol. 2008, 8:100-101.
33. Talwar G.P., Zaheer S.A., Mukherjee R., Walia R., Misra R.S., Sharma A.K., Kar H.K., Mukherjee A., Parida S.K., Suresh N.R., et al. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients. Vaccine 1990, 8:121-129.
34. Tree J.A., Elmore M.J., Javed S., Williams A., Marsh P.D. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination. Infect. Immun. 2006, 74:1436-1441.
35. Turner O.C., Basaraba R.J., Orme I.M. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect. Immun. 2003, 71:864-871.
36. Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., Huygen K., Ottenhoff T.H., Franken K.L., Andersen P., Doherty T.M., Kaufmann S.H., Grode L., Seiler P., Martin C., Gicquel B., Cole S.T., Brodin P., Pym A.S., Dalemans W., Cohen J., Lobet Y., Goonetilleke N., McShane H., Hill A., Parish T., Smith D., Stoker N.G., Lowrie D.B., Kallenius G., Svenson S., Pawlowski A., Blake K., Marsh P.D. Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis 2005, 85:29-38.
37. Yadava A., Mukherjee R. An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, Mycobacterium w, shares T and B cell determinants with M. leprae and M. tuberculosis. Med. Microbiol. Immunol. 1993, 182:243-253.
38. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.